Top Markets
Coin of the day
Ab&B Bio-Tech Co. Ltd. JS Ab&B Bio-Tech Co. Ltd. JS

Ab&B Bio-Tech Co. Ltd. JS

2627
Rank in Stocks #7741
Ab&B Bio-Tech Co., Ltd. engages in the research, development, manufacturing and... Ab&B Bio-Tech Co., Ltd. engages in the research, development, manufacturing and commercialization of innovative and traditional vaccines. Its products include quadrivalent subunit influenza and lyophilized human rabies vaccines. The company was founded by You Cai An on October 28, 2015 and is headquartered in Taizhou, China.
Share Price
$3.75
Last synced: 2026-04-28
Market Cap
$1.48B
Change (1 day)
0.00%
Change (1 year)
-44.31%
Country
CN
Trade Ab&B Bio-Tech Co. Ltd. JS (2627)

Category

Revenue for Ab&B Bio-Tech Co. Ltd. JS (2627)
Revenue in Aug 2026 TTM: 0
According to Ab&B Bio-Tech Co. Ltd. JS latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ab&B Bio-Tech Co. Ltd. JS from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$12.62B -
US
$6.02B -
NL
$15.74B -
AU
$2.23B -
US
- -
CH